Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Improved Gvhd-Relapse Free Survival of Ex Vivo αβtcr/CD19 Depleted Allo-Sct Combined with In Vivo T Cell Depletion with ATG When Compared to T Cell Replete Transplantations with or without the Addition of ATG

Moniek De Witte, Anniek Stuut, Klaartje Nijssen, Lotte Van Der Wagen, Anna Van Rhenen, Laura Daenen, Anke Janssen, Henk-Jan Prins, Kasper Westinga, Julia Drylewicz, Jurgen Kuball

Blood (2023) 142 (Supplement 1): 4931.

https://doi.org/10.1182/blood-2023-173621

Published: 2023

Journal Articles

First in Human Clinical Responses and Persistence Data on TEG001: A Next Generation of Engineered Αβ T Cells Targeting AML and MM with a High Affinity γ9δ2TCR

Moniek de Witte, Jojanneke Scheepstra, Naomi Weertman, Annet Daudeij, Lotte van der Wagen, Rimke Oostvogels, Colin de Haar, Henk-Jan Prins, Willem Dohmen, Carly Bartels-Wilmer, Inez Johanna, Zsolt Sebestyen, Jurgen Kuball, Trudy Straetemans

Blood (2022) 140 (Supplement 1): 12737–12739.

https://doi.org/10.1182/blood-2022-158191

Published: 2022

Journal Articles

First Results of a Prospective I/II Clinical Trial in Adult Patients Using TCR Alpha/Beta Depleted Stem Cell Transplantation from Matched Related and Unrelated Donors

Moniek De Witte, MD PhD, Anna Van Rhenen, MD PhD, Geerte Van Sluis, MD PhD, Rick Admiraal, MD PhD, Lotte van der Wagen, MD, Eefke J. Petersen, MD PhD, Reinier Raymakers, MD PhD, Monique C Minnema, MD PhD, Anke Janssen, MD, Kasper Westinga, BSc, Constantijn J.M. Halkes, MD, J.H. Frederik Falkenburg, MD PhD, Jaap Jan Boelens, MD PhD, Jurgen Kuball, MD

Blood (2018) 132 (Supplement 1): 2164.

https://doi.org/10.1182/blood-2018-99-112758

Published: 2018

Journal Articles

Efficacy of Bone Marrow Derived MSC for Steroid Refractory Acute GVHD Associates with Age and a Defined Molecular Profile of MSC Donors

Lotte van der Wagen, MD, Febilla Fernando, Nagesha Appukudige, PhD, Anke Janssen, MD, Kasper Westinga, Rick Admiraal, MD PhD, Magdalena Lorenowicz, PhD, Paul J. Coffer, PhD Prof, Sacha Zeerleder, PhDMD, Jeroen J. Janssen, MD PhD, Gerwin Huls, MD PhD, Annoek Broers, MD PhD, Walter JFM Van Der Velden, Marinus van Marwijk Kooij, MD PhD, Jaap Jan Boelens, MD PhD, Ineke Slaper-Cortenbach, PhD, Jurgen Kuball, MD

Blood (2017) 130 (Supplement 1): 1929.

https://doi.org/10.1182/blood.V130.Suppl_1.1929.1929

Published: 2017

Journal Articles

Treatment of Chronic Graft Versus Host Disease with a Combination of B-Cell Depletion and Tyrosine Kinase Inhibition

Lotte van der Wagen, MD, Liane CJ te Boome, MD, Inger Nijhof, Marieke Schoordijk, Denise Buter, Ellen Meijer, MDPhD, Jurgen Kuball, MDPhD

Blood (2015) 126 (23): 1939.

https://doi.org/10.1182/blood.V126.23.1939.1939

Published: 2015

Journal Articles

Development of an Alpha/Beta T-Cell Depleted Allogeneic Stem Cell Transplantation Protocol Form Matched Related and Unrelated Donor Grafts in Patients with Poor Risk Leukemia

Moniek A DeWitte, MDPhD, Liane te Boome, MD, Lotte van der Wagen, MD, Jurgen H Kuball, MDPhD

Blood (2014) 124 (21): 3885.

https://doi.org/10.1182/blood.V124.21.3885.3885

Published: 2014

Journal Articles

Feasibility Of αβT- Cell Depleted Allogeneic Stem Cell Transplantations From Matched Related and Unrelated Donor Grafts and Engraftment In Patients With Poor Risk Leukemia

Liane te Boome, MD, Lotte van der Wagen, MD., Kasper Westinga, Ineke Slaper-Cortenbach, PhD, Jurgen H Kuball, MD, PhD

Blood (2013) 122 (21): 2063.

https://doi.org/10.1182/blood.V122.21.2063.2063

Published: 2013

NARROW

Improved Gvhd-Relapse Free Survival of Ex Vivo αβtcr/CD19 Depleted Allo-Sct Combined with In Vivo T Cell Depletion with ATG When Compared to T Cell Replete Transplantations with or without the Addition of ATG

First in Human Clinical Responses and Persistence Data on TEG001: A Next Generation of Engineered Αβ T Cells Targeting AML and MM with a High Affinity γ9δ2TCR

First Results of a Prospective I/II Clinical Trial in Adult Patients Using TCR Alpha/Beta Depleted Stem Cell Transplantation from Matched Related and Unrelated Donors

Efficacy of Bone Marrow Derived MSC for Steroid Refractory Acute GVHD Associates with Age and a Defined Molecular Profile of MSC Donors

Treatment of Chronic Graft Versus Host Disease with a Combination of B-Cell Depletion and Tyrosine Kinase Inhibition

Development of an Alpha/Beta T-Cell Depleted Allogeneic Stem Cell Transplantation Protocol Form Matched Related and Unrelated Donor Grafts in Patients with Poor Risk Leukemia

Feasibility Of αβT- Cell Depleted Allogeneic Stem Cell Transplantations From Matched Related and Unrelated Donor Grafts and Engraftment In Patients With Poor Risk Leukemia

Email alerts

ASH Publications

American Society of Hematology

Improved Gvhd-Relapse Free Survival of Ex Vivo αβtcr/CD19 Depleted Allo-Sct Combined with In Vivo T Cell Depletion with ATG When Compared to T Cell Replete Transplantations with or without the Addition of ATG

First in Human Clinical Responses and Persistence Data on TEG001: A Next Generation of Engineered Αβ T Cells Targeting AML and MM with a High Affinity γ9δ2TCR

First Results of a Prospective I/II Clinical Trial in Adult Patients Using TCR Alpha/Beta Depleted Stem Cell Transplantation from Matched Related and Unrelated Donors

Efficacy of Bone Marrow Derived MSC for Steroid Refractory Acute GVHD Associates with Age and a Defined Molecular Profile of MSC Donors

Treatment of Chronic Graft Versus Host Disease with a Combination of B-Cell Depletion and Tyrosine Kinase Inhibition

Development of an Alpha/Beta T-Cell Depleted Allogeneic Stem Cell Transplantation Protocol Form Matched Related and Unrelated Donor Grafts in Patients with Poor Risk Leukemia

Feasibility Of αβT- Cell Depleted Allogeneic Stem Cell Transplantations From Matched Related and Unrelated Donor Grafts and Engraftment In Patients With Poor Risk Leukemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only